XML 176 R123.htm IDEA: XBRL DOCUMENT v3.24.0.1
Acquisitions - Additional information (Details) - USD ($)
$ / shares in Units, $ in Millions
 1 Months Ended 3 Months Ended 12 Months Ended
Nov. 21, 2022
Jan. 07, 2022
Dec. 31, 2022
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Significant Transactions [Line Items]              
Consideration paid         $ 0 $ 666 $ 0
Current income tax liabilities     $ 175   114 175  
Goodwill     8,926   8,926 8,926  
Release of contingent liability related to a recent acquisition         58 0 0
Pro forma net sales           8,776  
Pro forma net income           192  
Acquisitions of assets, net of cash acquired         $ 2 485 $ 0
Ivantis, Inc.              
Significant Transactions [Line Items]              
Percentage of voting equity interests acquired (as a percent)   100.00%          
Acquisitions of assets, net of cash acquired           477  
Upfront payment   $ 479          
Direct acquisition costs           2  
Aerie Pharmaceuticals, Inc.              
Significant Transactions [Line Items]              
Consideration paid $ 666            
Percentage of voting equity interests acquired (as a percent) 100.00%            
Price paid (in dollars per share) $ 15.25            
Consideration transferred $ 744            
Goodwill $ 65            
Release of contingent liability related to a recent acquisition       $ 58      
Acquisition and integration costs           $ 20  
Acquired business, increase in net sales     16        
Acquired business, reduction in net income     $ 32